Navigation

ExploreAnalysisInvestor RelationsAI AssistantCompareScreener
LoginSign Up FreeSign Up

© 2026 MarketCI. All rights reserved.

HelpPricingPrivacyTerms
AB

ABT

Market Closed

Abbott Laboratories

NYSEHealthcareMedical - Devices
US
115.00K employees
CEO: Robert Ford
Founded: 1980
$108.52
+$0.00(+NaN%)
Market Cap
187.95B
Beta
0.54
52W Range
N/A
Dividend Yield
2.32%
OverviewForecastsFundamentalMarket SentimentValuationOwnership
OverviewForecastsFundamentalMarket SentimentValuationOwnership
Comprehensive Valuation
In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Abbott Laboratories trades below its PERT-weighted fair value of $129.69, implying an 18.6% upside with high confidence. Strong financial health (4.0/5) aligns with robust valuation metrics, though Monte Carlo results reveal significant volatility and a 51.4% downside risk below current price. Valuation suggests potential opportunity tempered by notable risk exposure.
Enhanced Football Field Analysis
Loading comprehensive valuation data...

Fetching multi-methodology valuation ranges...

Explore ABT

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples

Ownership

Institutional and insider holdings

Sentiment

Analyst ratings and news sentiment

ABT in the Healthcare

Large Cap
Healthcare

Browse sector stocks →

Medical - Devices

Browse industry stocks →